Biotech for less than cash value | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotech for less than cash value

An SI Board Since April 2002

Posts	SubjectMarks	Bans
684	125	0

Emcee: RWReeves	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
109	INSM at $1.28 has about $1.28 per share in cash, major insider buying, Phase 2 c	RRICH4	-	7/17/2002
108	All the more reason to take out our buddy Saddam once and for all. Only in plac	Hank	-	7/12/2002
107	Did anyone mention CVAS ? <i> Cash, cash equivalents and investments at Ma	nigel bates	-	7/12/2002
106	<i>but doesn't it give you warm and fuzzies to know that we're con	tom pope	-	7/12/2002
105	>> there are other possible indications to think about such as weaponized	scaram(o)uche	-	7/12/2002
104	An interesting thing about the VPHM viral meningitis trial results was that the	RWReeves	-	7/12/2002
103	vphm's lead indication way back when (1995-1998) was viral meningitis. In sh	rkrw	-	7/11/2002
102	I agree. Cash doesn't mean too much if it's effectively earmarked for de	tom pope	-	7/11/2002
101	<i>They also have long term debt of $200MM...</i> In the current en	nigel bates	-	7/11/2002
100	>> On VPHM, I think they do have a meningitis indication in there if they	scaram(o)uche	-	7/11/2002
99	ABGX makes it unless you throw out good will and intangibles, which lowers the m	tom pope	-	7/11/2002
98	"But then you pulled the really good one..... paraphrased..... "if big	Hank	-	7/11/2002
97	Have not checked recently but wonder if the Humanized mab darlings of last gold	RWReeves	-	7/11/2002
96	>> First of all, it wasn't already known that the trial would fail. My	scaram(o)uche	-	7/11/2002
95	No, but I'd appreciate it if you'd fill me in.	Hank	-	7/11/2002
94	"Well, can you tell us why they plan to follow 50406 into the clinic with a	Hank	-	7/11/2002
93	I forgot to ask.... are you going to be attending the late breaker session tom	scaram(o)uche	-	7/10/2002
92	>> I don't have time to describe them "one by one". <<	scaram(o)uche	-	7/10/2002
91	I don't have time to describe them "one by one". Suffice it to sa	Hank	-	7/10/2002
90	>> All of the potential targets for RNA viruses have been thoroughly inves	scaram(o)uche	-	7/10/2002
89	VPHM is dead meat. Pleconaril was NEVER a good drug. It doesn't work equal	Hank	-	7/10/2002
88	Dov sued for late disclosure - Investment funds feel misled after disastrous IPO	Michael Young	-	7/10/2002
87	<<Dovp $63.0 $75.0 >> I've been tracking DOVP recently. Ha	Michael Young	-	7/9/2002
86	Good quote from AMEV's CFO in a very recent twst.com interview: "But	rkrw	-	7/9/2002
85	Hi Stefaan! Interesting observation that "acla is special case yahoo lists	RWReeves	-	7/9/2002

Go to reply# or date (mm/dd/yy):